SanBio Company Limited
SNBIF
$16.45
$2.1715.20%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.21M | 1.71M | 1.85M | 1.85M | 2.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.68M | 5.76M | 4.41M | 4.41M | 5.56M |
| Operating Income | -6.68M | -5.76M | -4.41M | -4.41M | -5.56M |
| Income Before Tax | -6.54M | -8.14M | 609.10K | 609.10K | -5.46M |
| Income Tax Expenses | -1.82M | -719.40K | 1.56M | 1.56M | -266.40K |
| Earnings from Continuing Operations | -4.72M | -7.42M | -953.40K | -953.40K | -5.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.72M | -7.42M | -953.40K | -953.40K | -5.20M |
| EBIT | -6.68M | -5.76M | -4.41M | -4.41M | -5.56M |
| EBITDA | -6.66M | -5.75M | -4.39M | -4.39M | -5.54M |
| EPS Basic | -0.07 | -0.11 | -0.01 | -0.01 | -0.08 |
| Normalized Basic EPS | -0.06 | -0.07 | 0.01 | 0.01 | -0.06 |
| EPS Diluted | -0.07 | -0.11 | -0.01 | -0.01 | -0.08 |
| Normalized Diluted EPS | -0.06 | -0.07 | 0.01 | 0.01 | -0.06 |
| Average Basic Shares Outstanding | 69.76M | 68.63M | 68.44M | 68.44M | 66.44M |
| Average Diluted Shares Outstanding | 69.76M | 68.63M | 68.44M | 68.44M | 66.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |